GLP-1 Medications for Asthma
Obesity worsens asthma control by reducing lung volume, increasing airway inflammation, and making rescue inhalers less effective. GLP-1 weight loss improves lung function, reduces asthma exacerbations, and may allow reduction of asthma medications in obese patients. Asthma affects approximately 25 million Americans with asthma, higher rates among those with obesity, and GLP-1 medications offer a clinically proven treatment option.
Prevalence
approximately 25 million Americans with asthma, higher rates among those with obesity
Recommended Medications
2
Treatment Type
GLP-1 Agonist
How GLP-1 Medications Help with Asthma
GLP-1 weight loss improves lung function, reduces asthma exacerbations, and may allow reduction of asthma medications in obese patients. For patients with asthma, GLP-1 medications address the underlying metabolic dysfunction that makes weight management difficult. Clinical trials have consistently shown that GLP-1 treatment produces significant improvements in both weight and condition-specific outcomes.
Recommended GLP-1 Medications for Asthma
Based on clinical evidence, the following GLP-1 medications are recommended for patients with asthma:
Semaglutide
Wegovy / Ozempic
Tirzepatide
Zepbound / Mounjaro
Detailed Medication Guides for Asthma
Asthma & GLP-1 FAQ
Can GLP-1 medications help with asthma?
Yes. GLP-1 weight loss improves lung function, reduces asthma exacerbations, and may allow reduction of asthma medications in obese patients. Clinical evidence supports the use of GLP-1 medications like semaglutide and tirzepatide for patients with asthma.
Which GLP-1 medication is best for asthma?
Semaglutide is often the first-line recommendation for asthma due to its strong clinical evidence. Your provider will evaluate your specific situation to determine the best option.
How much weight can I lose with GLP-1 if I have asthma?
Weight loss results are generally comparable to clinical trial averages (15-22% of body weight), though individual results vary based on the severity of asthma and other health factors.
How prevalent is asthma?
Asthma affects approximately 25 million Americans with asthma, higher rates among those with obesity. GLP-1 medications represent a significant treatment advancement for patients dealing with this condition alongside excess weight.